Freenome, Inc

FRNM Healthcare Diagnostics & Research

EPS
−115.2%
Free cash flow
+12.1%

Quarter to June 2026, against a year earlier

10.15 0.32 −3.06%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
17.81% (2.67%) (24.23%) (95.60%)

+6 more TTM periods

ROA
(0.86%) 0.12% 0.92% 2.67%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
26.43% (4.86%) (62.19%) 736.50%
Free Cash Flow per Share
(0.37) (0.38) (0.35) (0.26)
Free Cash Flow
(0.91) (0.92) (0.86) (0.63)
Other line items

Show all line items

Columns are period end dates